Partners Blog: AI in Healthcare – Setting a Common Perspective

Introduction It has become a truism in the pharmaceutical industry that new product performance is more often divergent from pre-launch forecasts than on target. In fact, less than 24% of major produ…

It is strategic planning season at many pharma companies. Even more than most years, planning strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While hi…

Download a PDF of this paper here.   M&A deals in biopharma often capture headlines for their large valuations, yet these figures rarely reflect the true financial return realized over time, …